Shares of Achillion Pharmaceuticals (ACHN) gain 14.7% premarket as the Bristol-Myers Squibb-Inhibitex merger stokes up M&A speculation over other Hepatitis C drug developers. Other names to watch: IDIX, VRTX
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/